Resources

We produce a range of outputs including reports for our stakeholders; journal articles reporting cutting edge methods and insights; dashboards of therapeutic interventions and diagnostic tests in development as well as exciting new digital tools such as ScanMedicine.

1,513

Technology Briefings

Reports

Live Dashboards

Visual Reports

Journal Articles

Indication
Interventions
Therapeutic Area
Month

Get in touch

Contact

A world leading Horizon Scanning Facility

Meet the Team

Our Mission & Values

Our Governance

Preparing health and care for what's next

What is Horizon Scanning?

Our Technical Infrastructure

Our Programmes

Capacity Building

CPD and Short Courses

Developing our People

Learning Opportunities

Engaging with a wide range of different audiences

Ecosystem Engagement

Public & Patient Involvement

Rare Diseases Medicines

Advanced Therapy Medicinal Products

Repurposed Medicines Dashboard

Resources

Resources

Indication

Interventions

Therapeutic Area

Month

Atogepant for the prevention of menstrual migraine

Elranatamab for treating newly-diagnosed multiple myeloma after autologous stem cell transplantation

Nemtabrutinib for untreated chronic lymphocytic leukaemia or small lymphocytic lymphoma

Ziltivekimab for reducing cardiovascular risk in patients with acute myocardial infarction

Sufentanil-ketamine for elective surgical procedures in children aged 1-17 years old

Ulefnersen for treating amyotrophic lateral sclerosis

Ziltivekimab for managing atherosclerotic cardiovascular disease, chronic kidney disease and systemic inflammation

IDP-126 for treating acne vulgaris

Lutikizumab for hidradenitis suppurativa in adults and adolescents

Glofitamab for treating relapsed or refractory mantle cell lymphoma

Ivonescimab for previously untreated PD-L1 positive metastatic non-small-cell lung cancer

Orforglipron for treating obesity or overweight with weight-related comorbidities in adolescents

Get in touch